Pacira | PCRX - 营业利润

金融业

USD

USD 1.21B

现金及等价物

USD 144.31M

USD 50.74M

USD 514.96M

USD 108.79M

USD 367.66M

USD 4.63M

USD 40.24M

790

EPS每股收益

USD 0.6

股本和储备

USD 653.89M

USD 126.64M

债务利息支出

USD 3.7M

USD 2.3M

USD 367.66M

USD 1.06B

USD 2.92M

USD 172.75M

USD 4.63M

普通股股本

USD 39.31M

38.58

USD 571K

USD 177M

销售和管理费用

USD 83.88M

USD 150.37M

贸易债权人

USD 14.01M

应收帐款人

USD 125.64M

	营业利润	更改		日
Assertio Holdings	USD -3.05M		569K	2024-09
Astellas Pharma	JPY 48.57B		85.97B	2026-03
Bristol-Myers Squibb	USD 4.2B		562M	2025-12
Cara Therapeutics	USD -5.94M		3.55M	2025-09
Coherus Biosciences	USD -39.08M		3.65M	2025-12
Heron Therapeutics	USD 38K		3.83M	2025-12
Ironwood Pharmaceuticals	USD 33.22M		7.58M	2024-12
J&J	USD 6.62B		1.03B	2026-03
Ligand Pharmaceuticals	USD 60.33M		40.29M	2026-03
Nektar Therapeutics	USD -19.09M		15.26M	2025-12
Novo Nordisk	DKK 59.62B		27.24B	2026-03
Omeros	USD -35.41M		23.75M	2024-09
Pacira	USD 4.62M		1.43M	2026-03
Perrigo	USD 33.6M		50.8M	2026-03
Pfizer	USD 4.99B		340M	2026-03
Supernus Pharmaceuticals	USD -35.25M		49.07M	2026-03
Teva Pharmaceutical Industries	USD 758M		271M	2026-03
Xeris Pharmaceuticals	USD 16.77M		10.04M	2025-12
Xoma	USD -15.64M		5.56M	2024-09
Zoetis	USD 865M		30M	2026-03